Axim Biotechnologies
AXIM Biotechnologies, Inc. is a vertically integrated research and development company based in New York, NY. They are dedicated to improving the diagnosis of ophthalmological conditions, such as Dry Eye Disease (DED), through the development of rapid diagnostic tests. With their two FDA Cleared Diagnostic tests for Dye Eye Disease, AXIM is at the forefront of ophthalmological diagnostics.
In addition to their focus on ophthalmological conditions, AXIM Biotechnologies is also actively involved in the development of diagnostic solutions for COVID-19 and oncological diseases. They are currently working on a rapid 10-minute serological diagnostic test that detects SARS-CoV-2 neutralizing antibodies (Nabs) and active biomarkers for early cancer detection. Through their vertically integrated research and development platform, AXIM has the capability to develop diagnostic solutions for a variety of conditions based on the needs of their clients.
Generated from the website
Also at this address
You might also like
Partial Data by Foursquare.